Croma Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Fort Lauderdale, FL and active since 2011.
Croma Pharmaceuticals Inc was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact David Muth at the company’s headquarters by writing to 100 Ne 3rd Avenue, Fort Lauderdale, Florida FL 33301 or by phoning (954) 334-3800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Croma Pharmaceuticals Inc |
| Contact Person: | David Muth |
| Address: | 100 Ne 3rd Avenue, Fort Lauderdale, Florida 33301 |
| Phone Number: | (954) 334-3800 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Croma Pharmaceuticals Inc was started in 2011 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David Muth for inquiries that concern Croma Pharmaceuticals Inc by calling the company number (954) 334-3800, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Croma Pharmaceuticals Inc can be found at the coordinates 26.123738,-80.140403 as well as the street address 100 Ne 3rd Avenue in Fort Lauderdale, Florida 33301.
For its online presence, you may visit Croma Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.